Double maintains 1 strategies that include ITOS - iTeos Therapeutics, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -29.02% | $99.63M | 0.59% |
| VIXY | -25.83% | $164.54M | 0.85% |
| BTAL | -25.48% | $296.22M | 1.43% |
| IVOL | -16.65% | $347.03M | 1.02% |
| XONE | -16.48% | $625.28M | 0.03% |
| CLIP | -14.44% | $1.51B | 0.07% |
| SPTS | -13.75% | $5.80B | 0.03% |
| SCHO | -13.49% | $11.03B | 0.03% |
| UTWO | -13.27% | $379.52M | 0.15% |
| IBTG | -12.30% | $1.92B | 0.07% |
| VGSH | -11.86% | $22.80B | 0.03% |
| IBTH | -11.60% | $1.62B | 0.07% |
| CARY | -10.45% | $347.36M | 0.8% |
| IBTI | -10.31% | $1.06B | 0.07% |
| UNG | -10.24% | $360.54M | 1.06% |
| FTSD | -10.00% | $231.81M | 0.25% |
| IBTJ | -9.30% | $688.19M | 0.07% |
| SHY | -8.91% | $23.83B | 0.15% |
| ICSH | -8.82% | $6.02B | 0.08% |
| CANE | -8.51% | $10.37M | 0.29% |
Yahoo
iTeos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.
Yahoo
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term value to shareholders - Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1 WATERTOWN, Mass. and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeut
Yahoo
Weeks after shelving a TIGIT drug prospect, the biotech is seeking to sell off its assets and intellectual property in a bid to "maximize" shareholder value.
Finnhub
Iteos Therapeutics Inc: * ITEOS THERAPEUTICS INC - EXPECTED SEVERANCE COSTS OF $21.8MILLION TO $24.7 MILLIONFurther company coverage: ...
Finnhub
ITeos Therapeutics plans towind down its operations and explore selling its assets,including experimental cancer treatments and an obesity program,the drug developer said on Wednesday, sending its...
SeekingAlpha
Is TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To Fail
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 46.62% | $44.57M | 0.5% |
| XBI | 44.11% | $4.82B | 0.35% |
| ARKG | 43.19% | $1.02B | 0.75% |
| IWC | 43.19% | $818.14M | 0.6% |
| IBB | 41.56% | $5.26B | 0.45% |
| PBE | 39.11% | $223.19M | 0.58% |
| IWO | 37.81% | $11.60B | 0.24% |
| IWM | 37.46% | $63.72B | 0.19% |
| VTWO | 37.42% | $12.52B | 0.07% |
| PBW | 37.29% | $271.53M | 0.65% |
| BBH | 37.21% | $330.62M | 0.35% |
| KOMP | 36.86% | $2.29B | 0.2% |
| KJAN | 36.67% | $287.30M | 0.79% |
| SCHA | 36.57% | $17.26B | 0.04% |
| KJUL | 36.34% | $119.50M | 0.79% |
| GSSC | 36.18% | $561.54M | 0.2% |
| ISCG | 36.14% | $681.20M | 0.06% |
| IWN | 35.85% | $10.96B | 0.24% |
| NUSC | 35.66% | $1.14B | 0.31% |
| SMMD | 35.59% | $1.45B | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AQB | -14.15% | $2.96M | -53.35% | 0.00% |
| CBOE | -13.77% | $24.23B | +35.36% | 1.09% |
| UNH | -8.26% | $279.00B | -37.22% | 2.74% |
| MKTX | -7.84% | $8.22B | +9.03% | 1.38% |
| ED | -7.19% | $36.00B | +12.64% | 3.34% |
| K | -5.67% | $27.76B | +41.17% | 2.85% |
| DFDV | -5.65% | $300.56M | +2,130.16% | 0.00% |
| CME | -5.60% | $99.39B | +40.68% | 3.86% |
| NOC | -5.22% | $71.81B | +14.14% | 1.69% |
| VHC | -4.93% | $48.19M | +108.24% | 0.00% |
| ZCMD | -4.43% | $29.55M | -8.59% | 0.00% |
| BULL | -4.29% | $6.47B | +25.76% | 0.00% |
| T | -3.86% | $203.71B | +51.55% | 3.92% |
| AIFU | -3.13% | $6.79B | +102.19% | 0.00% |
| PPC | -3.02% | $10.84B | +33.46% | 0.00% |
| CNC | -3.02% | $16.81B | -49.40% | 0.00% |
| LITB | -2.96% | $21.24M | -78.57% | 0.00% |
| MSEX | -2.93% | $1.00B | +5.97% | 2.41% |
| CABO | -2.74% | $766.56M | -61.04% | 6.49% |
| AWK | -2.49% | $27.36B | +9.65% | 2.21% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| JUCY | 0.02% | $269.70M | 0.6% |
| MMIT | 0.06% | $1.03B | 0.3% |
| TIPX | -0.09% | $1.74B | 0.15% |
| CTA | 0.16% | $1.06B | 0.76% |
| BOND | -0.19% | $5.67B | 0.7% |
| GNMA | -0.22% | $368.65M | 0.1% |
| SPAB | -0.23% | $8.82B | 0.03% |
| TFI | 0.26% | $3.22B | 0.23% |
| SPSB | 0.30% | $8.36B | 0.04% |
| TIP | 0.37% | $13.96B | 0.18% |
| NYF | 0.39% | $892.18M | 0.25% |
| USTB | -0.42% | $1.29B | 0.35% |
| BIL | 0.42% | $42.24B | 0.1356% |
| BBAG | -0.44% | $1.29B | 0.03% |
| PTBD | 0.44% | $138.28M | 0.6% |
| UUP | 0.48% | $201.63M | 0.77% |
| DFIP | 0.49% | $925.62M | 0.11% |
| TDTF | -0.53% | $847.78M | 0.18% |
| FLDR | -0.57% | $941.22M | 0.15% |
| DFNM | 0.59% | $1.57B | 0.17% |
Current Value
$10.161 Year Return
Current Value
$10.161 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BMRN | 46.09% | $10.96B | -29.40% | 0.00% |
| IMNM | 44.78% | $750.92M | -28.80% | 0.00% |
| RCUS | 43.70% | $909.55M | -40.18% | 0.00% |
| BDTX | 42.70% | $147.84M | -41.44% | 0.00% |
| AUTL | 42.19% | $625.43M | -32.66% | 0.00% |
| ALEC | 42.06% | $149.99M | -65.99% | 0.00% |
| NTLA | 41.88% | $1.11B | -53.25% | 0.00% |
| CRSP | 41.76% | $4.46B | -4.14% | 0.00% |
| OCUL | 41.53% | $1.51B | +41.41% | 0.00% |
| ARCT | 38.86% | $369.38M | -37.89% | 0.00% |
| DNLI | 38.84% | $2.16B | -30.05% | 0.00% |
| IDYA | 38.57% | $1.92B | -34.15% | 0.00% |
| EYPT | 38.30% | $664.72M | +12.07% | 0.00% |
| ARWR | 38.10% | $2.33B | -32.59% | 0.00% |
| FATE | 37.96% | $128.39M | -64.56% | 0.00% |
| CGEM | 37.95% | $457.95M | -53.75% | 0.00% |
| CRBU | 37.89% | $127.42M | -14.38% | 0.00% |
| MGNX | 37.68% | $87.06M | -67.14% | 0.00% |
| RXRX | 36.65% | $2.12B | -29.12% | 0.00% |
| ABCL | 36.16% | $1.12B | +38.38% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GIS | 0.01% | $29.20B | -14.66% | 4.47% |
| DHT | 0.02% | $1.76B | -3.95% | 7.32% |
| VSTA | -0.02% | $344.07M | +39.29% | 0.00% |
| CHD | -0.07% | $24.14B | -7.11% | 1.19% |
| CIG.C | -0.08% | $2.65B | +29.61% | 0.00% |
| CHE | -0.21% | $6.89B | -12.73% | 0.42% |
| CORT | 0.22% | $7.57B | +133.90% | 0.00% |
| DRD | -0.29% | $1.18B | +51.33% | 2.03% |
| TRMD | 0.37% | $1.67B | -56.24% | 23.20% |
| DUK | 0.37% | $90.99B | +17.25% | 3.56% |
| DOGZ | 0.38% | $121.58M | -48.38% | 0.00% |
| CWT | 0.38% | $2.75B | -3.24% | 2.50% |
| HRZN | 0.40% | - | - | 17.86% |
| CL | 0.41% | $74.88B | -3.64% | 2.19% |
| OSCR | 0.44% | $4.23B | -2.64% | 0.00% |
| IMNN | 0.45% | $16.26M | -34.16% | 0.00% |
| ACHC | -0.49% | $2.14B | -65.25% | 0.00% |
| KR | 0.54% | $46.43B | +38.38% | 1.85% |
| GORV | -0.57% | $27.07M | -91.17% | 0.00% |
| DVA | 0.57% | $10.76B | +3.34% | 0.00% |
